Pharmaceutical formulation of a didemnin compound
US8420130B1 · kind B1 · utility
8Cited by
20References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 18, 1999 |
| Grant date | Apr 16, 2013 |
| Priority date | — |
| Expiry date | Feb 18, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/44
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A stable pharmaceutical composition of a didemnin compound, comprises firstly a lyophilized didemnin preparation including water-soluble material and secondly a reconstitution solution of mixed solvents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.